Page 242 - 82_ex2

Rafael Moncada, Manuel F. Landecho, Víctor Valentí, Gema Frühbeck
Management of obesity. Lancet
2016;387(10031):1947-56.
7 Buchwald H, Avidor Y, Braunwald E, Jensen MD,
Pories W, Fahrbach K et al. Bariatric surgery: a
systematic review and meta-analysis. JAMA
2004;292:1724-37.
8 Sjöström L, Lindroos AK, Peltonen M, Torgerson J,
Bouchard C, Carlsson B et al. Lifestyle, diabetes, and
cardiovascular risk factors 10 years after bariatric
surgery. N Engl J Med 2004;351:2683-93.
9 Sjöström L, Narbro K, Sjöström CD, Karason K,
Larsson B, Wedel H et al. Effects of bariatric surgery
on mortality in Swedish obese subjects. N Engl J Med
2007;357:741-52.
10 Sjöström L. Bariatric surgery and reduction in
morbidity and mortality: experiences from the SOS
study. Int J Obes (Lond) 2008;32 Suppl 7:S93-7.
11 Sjostrom L, Gummesson A, Sjostrom CD, Narbro K,
Peltonen M, Wedel H et al. Effects of bariatric surgery
on cancer incidence in obese patients in Sweden
(Swedish Obese Subjects Study): a prospective,
controlled intervention trial. Lancet Oncol
2009;10:653-62.
12 Sjöström L, Peltonen M, Jacobson P, Sjöström CD,
Karason K, Wedel H et al. Bariatric surgery and long-
term cardiovascular events. JAMA 2012;307:56-65.
13 Sjöström L. Review of the key results from the
Swedish Obese Subjects (SOS) trial - a prospective
controlled intervention study of bariatric surgery. J
Intern Med 2013;273:219-34.
14 Sjostrom L, Peltonen M, Jacobson P, Ahlin S,
Andersson-Assarsson J, Anveden A et al. Association
of bariatric surgery with long-term remission of type 2
diabetes and with microvascular and macrovascular
complications. JAMA 2014;311:2297-304.
15 Frühbeck G. Bariatric and metabolic surgery: a shift in
eligibility and success criteria. Nat Rev Endocrinol
2015;11:465-77.
16 Flegal KM, Kit BK, Orpana H, Graubard BI.
Association of all-cause mortality with overweight
and obesity using standard body mass index
categories: a systematic review and meta-analysis.
JAMA 2013;309:71-82.
17 Frühbeck G, Toplak H, Woodward E, Yumuk V,
Maislos M, Oppert JM. Obesity: the gateway to ill
health - an EASO position statement on a rising public
health, clinical and scientific challenge in Europe.
Obes Facts 2013;6:117-20.
18 Colquitt JL, Pickett K, Loveman E, Frampton GK.
Surgery for weight loss in adults. Cochrane Database
Syst Rev 2014;8:CD003641.
19 Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ,
Colditz GA. The effectiveness and risks of bariatric
surgery: an updated systematic review and meta-
analysis, 2003-2012. JAMA Surg 2014;149:275-87.
20 Lutz TA, Bueter M. Physiological mechanisms behind
232 @Real Academia Nacional de Farmacia. Spain
Roux-en-Y gastric bypass surgery. Dig Surg
2014;31:13-24.
21 Madsbad S, Dirksen C, Holst JJ. Mechanisms of
changes in glucose metabolism and bodyweight after
bariatric surgery. Lancet Diabetes Endocrinol
2014;2:152-64.
22 Arble DM, Sandoval DA, Seeley RJ. Mechanisms
underlying weight loss and metabolic improvements
in rodent models of bariatric surgery. Diabetologia
2015;58:211-20.
23 Auguet T, Terra X, Hernandez M, Sabench F, Porras
JA, Orellana-Gavalda JM et al. Clinical and
adipocytokine changes after bariatric surgery in
morbidly obese women. Obesity (Silver Spring)
2014;22:188-94.
24 Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein
S. Visceral fat adipokine secretion is associated with
systemic inflammation in obese humans. Diabetes
2007;56:1010-3.
25 Evans J, Goedecke JH, Soderstrom I, Buren J,
Alvehus M, Blomquist C et al. Depot- and ethnic-
specific differences in the relationship between
adipose tissue inflammation and insulin sensitivity.
Clin Endocrinol 2011;74:51-9.
26 Chabot K, Rabasa-Lhoret R, Gauthier MS. Evaluation
of the relationship between adipose tissue
inflammation and the development of systemic insulin
resistance in obese humans before and after bariatric
surgery. Can J Diabetes 2013;37:59.
27 Cheng V, Kashyap SR, Schauer PR, Kirwan JP,
McCrae KR. Restoration of glycemic control in
patients with type 2 diabetes mellitus after bariatric
surgery is associated with reduction in microparticles.
Surg Obes Relat Dis 2013;9:207-12.
28 Dalbeth N, Pool B, Yip S, Cornish J, Murphy R.
Effect of bariatric surgery on the inflammatory
response to monosodium urate crystals: a prospective
study. Ann Rheum Dis 2013;72:1583-4.
29 Felipo V, Urios A, Garcia-Torres ML, El Mlili N, del
Olmo JA, Civera M et al. Alterations in
adipocytokines and cGMP homeostasis in morbid
obesity patients reverse after bariatric surgery. Obesity
(Silver Spring) 2013;21:229-37.
30 Fenske WK, Dubb S, Bueter M, Seyfried F, Patel K,
Tam FW et al. Effect of bariatric surgery-induced
weight loss on renal and systemic inflammation and
blood pressure: a 12-month prospective study. Surg
Obes Relat Dis 2013;9:559-68.
31 de Jonge C, Rensen SS, D'Agnolo HM, Bouvy ND,
Buurman WA, Greve JW. Six months of treatment
with the endoscopic duodenal-jejunal bypass liner
does not lead to decreased systemic inflammation in
obese patients with type 2 diabetes. Obes Surg
2014;24:337-41.
32 Johnson BL, Blackhurst DW, Latham BB, Cull DL,
Bour ES, Oliver TL et al. Bariatric surgery is
associated with a reduction in major macrovascular